A Key Role of Insulin in Diabetes Mellitus

Authors

  • Aarif Ali  Division of Veterinary Biochemistry SKUAST-K Shuhama Kashmir, India
  • Aadil Ayaz  Department of Zoology and Biotechnology, HNBG University, Uttarakhand, India
  • Mashooq Ahmad Dar  Division of Veterinary Biotechnology,SKUAST-K, Shuhama, Kashmir, India
  • N. Singh  Department of Zoology and Biotechnology, HNBG University, Uttarakhand, India
  • Showkat Ahmad Bhat  Division of Veterinary Biochemistry SKUAST-K Shuhama Kashmir, India

Keywords:

Diabetes Mellitus, Prevelance, Insulin, Oxidative Stress, Complications.

Abstract

Diabetes mellitus is an endocrine metabolic disorder with the characteristic feature of hyperglycemia i.e increased glucose levels. It usually occurs due to the disturbances in carbohydrate metabolism. Glucose is an important aldohexose sugar whose level gets raised during diabetes. Normally in the body glucose is acted upon by the hormone Insulin which is secreted by the beta islet cells of the pancreas. However during diabetes either the level of insulin decreases or the cells become insensitive to the action of insulin. Diabetes mellitus is associated with a number of complications affecting eyes, kidney, heart, nerves etc. A lot of research is done or is still is going on, but diabetes mellitus still is the leading cause of death worldwide. The number of diabetic cases in developing countries is increasing day by day and no huge effort has been put into action to stop this sweet but deadly disease. Diabetes mellitus can be controlled by diet, lifestyle, exercise, oral hypoglycemic agents or insulin (pharmacological). Diabetes mellitus selectively damages cells(endothelial cells and mesangial cells) because in these cells the rate of glucose transport does not decline rapidly as a result of hyperglycemia, leading to high glucose inside the cell. Diabetes mellitus not only affects small blood vessels but also large blood vessels, so the complications of diabetes are divided into two classes i.e microvascular(small blood vessels) and macrovascular (large blood vessels).These complications affect and cause severe damage not only to the organs but to the nerves as well. So such medications should be developed that at least should minimize these adverse damages. At the moment insulin is widely used in diabetes in combination with other medicines. Not only drugs but products obtained from natural sources which could act as a protective agents should be looked upon to reverse and decrease such adverse damages. In this review main focus has been given on insulin molecule(synthesis, secretion, action,etc) and its role in diabetes mellitus.

References

  1. Ahmed, K.A., Muniandy, S and Ismail, I.S. (2010), Type 2 diabetes and vascular complications: A pathophysiologic view, Biomedical Research, 21, 147-155.
  2. Bell G I, Picket RL, Rutter WJ et al. Sequence of the human insulin gene. Nature 1980; 284: 26-32.
  3. Hutton JC. Insulin secretory granule biogenesis and the proinsulin-processing endopeptidases. Diabetologia 1994; 37 (Suppl.2): S48-56
  4. Dodson G, Steiner D. The role of assembly in insulin’s biosynthesis. Curr Opin Struct Biol. 1998;8:189-94.
  5. De Lonlay, Saudubray J-M. Persistent hyperinsulinaemic hypoglycaemia. In: Fernandes J, Sudubray J-M, van den Berghe editors Inborn Metabolic Diseases: Diagnosis and treatment. (3rd ed): Springer, Heidelberg Germany; 2000 p.117-26.
  6. Nielsen JH, Galsgaard ED, Moldrup A, et al. Regulation of beta-cell mass by hormones and growth factors Diabetes. 2001;50 Suppl 1:S25-9.
  7. Bratanova-Tochkova TK, Cheng H, Daniel S, et al. Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 2002;51 Suppl. 1:S83-90.
  8. Home PD. Insulin therapy. In: Alberti KGMM, Zimmet P, Defronzo RA editors & Keen H (Hon) editor International Textbook of Diabetes Mellitus (2nd ed) John Wiley & Sons, New York; 1997 p. 899-928.
  9. Burks DJ, White MF. IRS proteins and beta-cell function. Diabetes. 2001;50 Suppl 1:S140-5.
  10. Karam JH. Pancreatic Hormones and Diabetes Mellitus.In: Greenspan FS, Strewler GJ, editors. Basic and Clinical Endocrinology. Appleton & Lange, Stamford CT USA; 1997 p.601-2.
  11. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2197-223
  12. Brophy, S., Brunt, H., Davies, H., Mannan,S and Williams, R.(2007), Interventions for latent autoimmune diabetes (LADA) in adults, Cochrane Database of Systemic Reviews, 3, CD006165.
  13. Maiese, K., Shang, Y.C., Chong, Z.Z and Hou, J. (2010), Diabetes mellitus: Channeling care through cellular discovery, Current NeurovascularResearch, 7, 59-64.
  14. Rebecchi, K.R., Wenke, J.L., Go, E.P and Desaire, H. (2009), Label-free quantitation: a new glycoproteomics approach, Journal of the American Society for Mass Spectrometry, 20, 1048–1059.
  15. Fowler, M.J. (2008), Microvascular and macrovascular complications of diabetes, Clinical Diabetes, 26, 77-82.
  16. Daneman, D. (2006), Type 1 diabetes, Lancet, 367, 847-58.
  17. Chandramohan, G., Al-Numair, K. S and Pugalendi, K. V(2009), Effect of 3-hydroxymethyl xylitol on hepatic and renal functional markers and protein levels in streptozotocin diabetic rats, African Journal of Biochemistry Research, 3, 198-204.
  18. Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes. 2008;26(2):77-82. 304 Lipid Peroxidation
  19. Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL. Vitamin E prevents diabetes induced abnormal retinal blood flow via the diacylglycerolprotein kinase C pathway. American Journal of Physiology. 1995;269: E239– E246.
  20. Watkins PJ. Retinopathy. BMJ.2003;326:924–926.
  21. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA & Holman RR (2003). Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International. 2003;63:225–232.
  22. Maritim, A. C., R. A. Sanders & J. B. Watkins. Diabetes, oxidative stress, and antioxidants: A review. Journal of Biochemical and Molecular Toxicology. 2003;17:24- 38.
  23. Kunisaki M, Bursell SE, Clermont AC, Ishii H, Ballas LM, Jirousek MR, Umeda F, Nawata H, King GL. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. American Journal of Physiology- Endocrinology and Metabolism. 1995;269(2):E239-E46.
  24. de Lemos ET, Pinto Ri Oliveira J, Garrido P, Sereno J, Mascarenhas-Melo F, Pascoa Pinheiro J, Teixeira F & Reis F. (2011). Differential effects of acute (extenuating) and chronic (training) exercise on inflammation and oxidative stress status in an animal model of Type 2 diabetes mellitus. Mediators of Inflammation. 2011;253061:1-8.
  25. Perez-Matute P, Zulet MA & Mart´?nez JA (2009). Reactive species and diabetes: Counteracting oxidative stress to improve health. Current Opinion in Pharmacology. 2009;9(6):771–779.
  26. Brunner Y, Schvartz D, Priego-Capote F, Cout´e Y & Sanchez JC (2009). Glucotoxicity and pancreatic proteomics. Journal of Proteomics.2009;71(6):576–591.
  27. Chen, H., Li, X and Epstein, P.N. (2005), Mn-SOD and catalase transgenes demonstrate that protection of islets from oxidative stress does not alter cytokine toxicity, Diabetes, 54, 1437–46.
  28. Li, N., Frigerio, F and Maechler, P. (2008), The sensitivity of pancreatic ?-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress, Biochemical Society Transactions, 36, 930–934.
  29. Choo, H.J., Kim, J.H., Kwon, O.B., Lee, C.S., Mun, J.Y., Han, S.S., Yoon, Y.S., Yoon,G.,Choi, K.M and Ko, Y.G.. (2006), Mitochondria are impaired in the adipocytes of type 2 diabetic mice, Diabetologia, 49, 784-91.

Downloads

Published

2017-10-31

Issue

Section

Research Articles

How to Cite

[1]
Aarif Ali, Aadil Ayaz, Mashooq Ahmad Dar, N. Singh, Showkat Ahmad Bhat, " A Key Role of Insulin in Diabetes Mellitus, International Journal of Scientific Research in Science, Engineering and Technology(IJSRSET), Print ISSN : 2395-1990, Online ISSN : 2394-4099, Volume 3, Issue 6, pp.80-85, September-October-2017.